These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 10487616)

  • 1. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.
    Barber MD; Ross JA; Voss AC; Tisdale MJ; Fearon KC
    Br J Cancer; 1999 Sep; 81(1):80-6. PubMed ID: 10487616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement.
    Barber MD; McMillan DC; Preston T; Ross JA; Fearon KC
    Clin Sci (Lond); 2000 Apr; 98(4):389-99. PubMed ID: 10731472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia.
    Barber MD; Fearon KC; Tisdale MJ; McMillan DC; Ross JA
    Nutr Cancer; 2001; 40(2):118-24. PubMed ID: 11962246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
    Wigmore SJ; Barber MD; Ross JA; Tisdale MJ; Fearon KC
    Nutr Cancer; 2000; 36(2):177-84. PubMed ID: 10890028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients.
    Barber MD; Preston T; McMillan DC; Slater C; Ross JA; Fearon KC
    Clin Sci (Lond); 2004 Apr; 106(4):359-64. PubMed ID: 14624668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer.
    Bauer J; Capra S; Battistutta D; Davidson W; Ash S;
    Clin Nutr; 2005 Dec; 24(6):998-1004. PubMed ID: 16140426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
    Cerchietti LC; Navigante AH; Castro MA
    Nutr Cancer; 2007; 59(1):14-20. PubMed ID: 17927497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of oral nutritional supplements in patients with Huntington's disease.
    Trejo A; Boll MC; Alonso ME; Ochoa A; Velásquez L
    Nutrition; 2005 Sep; 21(9):889-94. PubMed ID: 16087319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of a protein and energy dense eicosapentaenoic acid containing supplement for malignancy-related weight loss in children.
    Bayram I; Erbey F; Celik N; Nelson JL; Tanyeli A
    Pediatr Blood Cancer; 2009 May; 52(5):571-4. PubMed ID: 19090549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
    Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
    J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional support and quality of life in stable chronic obstructive pulmonary disease (COPD) patients.
    Planas M; Alvarez J; García-Peris PA; de la Cuerda C; de Lucas P; Castellà M; Canseco F; Reyes L
    Clin Nutr; 2005 Jun; 24(3):433-41. PubMed ID: 15896431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia.
    Fearon KC; Barber MD; Moses AG; Ahmedzai SH; Taylor GS; Tisdale MJ; Murray GD
    J Clin Oncol; 2006 Jul; 24(21):3401-7. PubMed ID: 16849754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
    Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
    Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial.
    Sánchez-Lara K; Turcott JG; Juárez-Hernández E; Nuñez-Valencia C; Villanueva G; Guevara P; De la Torre-Vallejo M; Mohar A; Arrieta O
    Clin Nutr; 2014 Dec; 33(6):1017-23. PubMed ID: 24746976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy.
    Murphy RA; Mourtzakis M; Chu QS; Baracos VE; Reiman T; Mazurak VC
    Cancer; 2011 Apr; 117(8):1775-82. PubMed ID: 21360698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial.
    Simons JP; Schols AM; Hoefnagels JM; Westerterp KR; ten Velde GP; Wouters EF
    Cancer; 1998 Feb; 82(3):553-60. PubMed ID: 9452274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids.
    Moses AW; Slater C; Preston T; Barber MD; Fearon KC
    Br J Cancer; 2004 Mar; 90(5):996-1002. PubMed ID: 14997196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.
    Fearon KC; Von Meyenfeldt MF; Moses AG; Van Geenen R; Roy A; Gouma DJ; Giacosa A; Van Gossum A; Bauer J; Barber MD; Aaronson NK; Voss AC; Tisdale MJ
    Gut; 2003 Oct; 52(10):1479-86. PubMed ID: 12970142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional treatment for acquired immunodeficiency virus infection using an enterotropic peptide-based formula enriched with n-3 fatty acids: a randomized prospective trial.
    de Luis Román DA; Bachiller P; Izaola O; Romero E; Martin J; Arranz M; Eiros Bouza JM; Aller R
    Eur J Clin Nutr; 2001 Dec; 55(12):1048-52. PubMed ID: 11781670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.